Creatinine and eGFR — the standard markers of kidney function on every metabolic panel — have a blind spot. They are heavily influenced by muscle mass, which means a lean elderly woman and a muscular 30-year-old man could have the same creatinine level while having vastly different kidney function.
Cystatin C solves this problem. It is a small protein produced at a near-constant rate by every nucleated cell in the body, freely filtered by the kidneys, and — crucially — not affected by muscle mass, sex, or diet. This makes it a more accurate and equitable measure of kidney filtration.
Longevity physicians now consider it one of the 9 essential biomarkers. Here is why.
What cystatin C measures
The kidneys filter blood at a rate called the glomerular filtration rate (GFR). When kidney function declines, GFR drops, and waste products accumulate in the blood. We cannot measure GFR directly in clinical practice, so we use proxy markers:
- Creatinine: a waste product of muscle metabolism, filtered by the kidneys. The traditional marker.
- Cystatin C: a protease inhibitor produced by all nucleated cells at a constant rate, freely filtered by the kidneys.
Both rise when kidney function declines. But cystatin C is more reliable because its production rate is independent of external factors that confound creatinine.
Why cystatin C is superior
Creatinine's problems
Creatinine is cheap and widely available, but it has significant limitations:
- Muscle mass dependency: A bodybuilder with GFR of 120 mL/min may have creatinine of 1.3 mg/dL (flagged high). An elderly woman with GFR of 50 mL/min may have creatinine of 0.9 mg/dL (appears normal). Same test, completely different interpretations.
- Diet influence: High-protein diets and creatine supplementation raise creatinine independent of kidney function.
- Race-based correction controversy: Creatinine-based eGFR formulas historically used a race coefficient that was scientifically questionable and has now been removed (CKD-EPI 2021).
- Blind spot in early decline: Creatinine-based eGFR can remain "normal" until kidney function has declined 30–50% — a concept called the creatinine-blind range.
Cystatin C's advantages
- Not affected by muscle mass — reliable in athletes, elderly, amputees, and people with low muscle mass
- Not affected by sex or diet — no adjustment needed
- Better predictor of outcomes — the NEJM study (Shlipak et al. 2013) showed that cystatin C-based eGFR better predicted cardiovascular events, heart failure, and death than creatinine-based eGFR
- Earlier detection — catches GFR decline earlier, particularly in the 60–90 mL/min range where creatinine-based eGFR may still appear normal
- Better for risk stratification — when creatinine and cystatin C disagree, the cystatin C value more accurately predicts adverse outcomes
Cystatin C reference ranges
| Cystatin C (mg/L) | Interpretation |
|---|---|
| Below 0.7 | Excellent kidney function |
| 0.7–0.9 | Optimal |
| 0.9–1.0 | Normal but monitor |
| 1.0–1.2 | Mildly elevated — early kidney dysfunction possible |
| 1.2–1.5 | Elevated — moderate kidney impairment likely |
| Above 1.5 | High — significant kidney dysfunction |
The corresponding eGFR (estimated from cystatin C) can be calculated using the CKD-EPI cystatin C equation. An eGFR above 90 mL/min/1.73m² is considered normal; below 60 is chronic kidney disease.
Why longevity physicians care about kidneys
Kidney function is one of the strongest predictors of lifespan. The kidneys filter approximately 180 liters of blood per day — they are the body's primary filtration system. When they decline:
- Cardiovascular risk rises dramatically — CKD is an independent risk factor for heart disease, stronger than diabetes in many analyses
- Toxin clearance declines — leading to systemic inflammation and oxidative stress
- Blood pressure regulation fails — the kidneys control fluid balance and the renin-angiotensin system
- Anemia develops — the kidneys produce erythropoietin (EPO), essential for red blood cell production
- Bone health declines — the kidneys activate vitamin D and regulate calcium/phosphate balance
The 9 essential longevity biomarkers now consistently include a kidney function marker — and increasingly, that marker is cystatin C rather than (or in addition to) creatinine.
What accelerates kidney decline
- Uncontrolled hypertension — the number one cause of kidney damage in developed countries
- Diabetes and insulin resistance — hyperglycemia damages glomerular capillaries
- NSAIDs (ibuprofen, naproxen) — chronic use directly harms kidney function
- Dehydration — particularly chronic mild dehydration in active individuals
- High-protein diets in those with existing CKD — not harmful to healthy kidneys, but accelerates decline in damaged ones
- Smoking — damages renal vasculature
- Uric acid — hyperuricemia damages renal tubules
How to protect kidney function
- Control blood pressure — target below 120/80 mmHg
- Manage blood sugar — keep HbA1c below 5.7%, fasting insulin low
- Stay hydrated — 2–3 liters of water daily
- Limit NSAID use — use acetaminophen instead for pain when possible (with attention to liver dosing limits)
- Exercise regularly — cardiovascular fitness supports renal blood flow
- Monitor — track cystatin C or creatinine-based eGFR annually
The combined approach
The most accurate kidney function estimate uses both creatinine and cystatin C together (the CKD-EPI creatinine-cystatin C equation). When the two markers disagree — creatinine says kidneys are fine but cystatin C suggests they are not — cystatin C is more often correct, and the patient is at higher risk than creatinine alone would suggest.
How Merios helps
Upload your metabolic panel to Merios and we extract creatinine, BUN, eGFR, and cystatin C (when available). Track your kidney function trend over time and see it alongside blood pressure, uric acid, and metabolic markers. Catching a slow decline early is the entire point of tracking.
Track your kidney function with Merios →
This article is for informational purposes only and does not constitute medical advice. Discuss kidney function testing with your physician.